Compare Select Medical Holdings Corporation (SEM) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Select Medical Holdings Corporation vs BIO-TECHNE Corp — how do they compare? Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 5.4× Select Medical Holdings Corporation's market cap, and Select Medical Holdings Corporation pays the higher dividend (1.51%). Which is the better fit depends on your goals.
| SEM | TECH | |
|---|---|---|
Market Cap | $2.05B | $11.16B |
Sector | Health | Health |
52-Week High | $16.66 | $72.12 |
52-Week Low | $11.77 | $43.31 |
Enterprise Value | $5.01B | $11.24B |
Dividend Yield | 1.51% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
